Comparison of EGFR-TKI and Chemotherapy in the First-Line Treatment of Advanced EGFR Mutation-Positive NSCLC
Neoplasma - Slovakia
doi 10.4149/neo_2013_055
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 2013
Authors
Publisher
AEPress, s.r.o.